# Q-Line Biotech, a healthcare solutions provider, has raised a little over Rs 61 crore from anchor investors.

*biotech · news · 2026-05-20 · Devdiscourse*

## Key points

- Q-Line Biotech raised Rs 61.09 crore from anchor investors at Rs 343 per share.
- The IPO is a fresh issue of 62.53 lakh equity shares with face value Rs 10 each.
- IPO proceeds will fund working capital, debt repayment, and general corporate purposes.
- Q-Line Biotech reported Rs 232.42 crore revenue and Rs 38.7 crore PAT for nine months ending December 2025.
- Shares are set to list on NSE SME Emerge with a tentative listing date of May 29, 2026.

**Companies:** HDFC Bank, Q-Line Biotech, Hem Securities Ltd
**Countries:** India

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3915874-q-line-biotech-mobilises-over-rs-61-cr-from-anchor-investors-ipo-to-open-on-thursday)

---

Canonical: https://newsio.io/n/2a6f1aa7-b5fb-4a26-bf0c-5bcd6ecd85f5/q-line-biotech-a-healthcare-solutions-provider-has-raised-a-little-over-rs-61-cr
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works